Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Effects of Exemestane on Bone Strength (MAP3BSS)

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
Canadian Breast Cancer Research Alliance
Information provided by (Responsible Party):
University Health Network, Toronto
ClinicalTrials.gov Identifier:
NCT01144468
First received: June 11, 2010
Last updated: July 9, 2013
Last verified: July 2013